Page last updated: 2024-09-03

l 640035 and enalapril

l 640035 has been researched along with enalapril in 1 studies

Compound Research Comparison

Studies
(l 640035)
Trials
(l 640035)
Recent Studies (post-2010)
(l 640035)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
13006,3111,924859

Protein Interaction Comparison

ProteinTaxonomyl 640035 (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, CC; Ford-Hutchinson, A1

Other Studies

1 other study(ies) available for l 640035 and enalapril

ArticleYear
Potentiation of the inhibitory effect of a thromboxane A2 antagonist (L-640,035) on arterial thrombosis formation in rabbit by the angiotensin converting enzyme inhibitor enalapril.
    European journal of pharmacology, 1985, Apr-16, Volume: 110, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Dibenzothiepins; Dipeptides; Drug Synergism; Enalapril; Female; Hexamethonium Compounds; Hydralazine; Male; Prostaglandin Antagonists; Rabbits; Radioimmunoassay; Thrombosis; Thromboxane A2; Thromboxanes

1985
chemdatabank.com